Webinar : The Challenges of Resistance to Immunotherapy & Predicting Treatment Response | Replay available
Relive the webinar on “𝙏𝙝𝙚 𝘾𝙝𝙖𝙡𝙡𝙚𝙣𝙜𝙚𝙨 𝙤𝙛 𝙍𝙚𝙨𝙞𝙨𝙩𝙖𝙣𝙘𝙚 𝙩𝙤 𝙄𝙢𝙢𝙪𝙣𝙤𝙩𝙝𝙚𝙧𝙖𝙥𝙮 𝙖𝙣𝙙 𝙋𝙧𝙚𝙙𝙞𝙘𝙩𝙞𝙣𝙜 𝙏𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩 𝙍𝙚𝙨𝙥𝙤𝙣𝙨𝙚,” that brought together two leading clinicians and two PSCC-supported startups developing innovative approaches to better predict treatment response.
🎤 With:
• Michel Ducreux, Professor of Oncology at Paris-Saclay University and Head of Gastrointestinal Oncology at Gustave Roussy.
• François-Xavier Danlos, Medical Oncologist and Researcher at Gustave Roussy, specializing in immunotherapy and precision medicine.
• Arnaud Cutivet, co-founder & CEO of MSInsight, which develops solutions combining genomics and AI to improve the detection and interpretation of tumor and genetic biomarkers.
• Etienne Formstecher, co-founder & CEO of GMT Science, which develops diagnostic tests combining gut microbiome analysis and AI.
See the replay :
